参考文献/References:
［1］Huchon C, Deffieux X, Beucher G, et al. Pregnancy loss: French clinical practice guidelines ［J］. Eur J Obstet Gynecol Reprod Biol, 2016, 201: 18-26.
［2］Bolze PA, Attia J, Massardier JA, et al. Formalised consensus of the European Organisation for Treatment of Trophoblastic Diseases on management of gestational trophoblastic diseases［J］. Eur J Cancer, 2015, 51(13): 1725-1731.
［3］杨 婧，王雪燕，周 玮.妊娠合并滋养细胞疾病临床研究进展［J］.中国实用妇科与产科杂志，2017,33（2）：225-228.
［4］Schwentner L, Schmitt W, Bartusek GA, et al. Cervical hydatidiform mole pregnancy after missed abortion presenting with severe vaginal bleeding: case report and review of the literature ［J］. Eur J Obstet Gynecol Reprod Biol, 2011, 156(1): 9-11.
［5］NganHYS，SecklMJ，BerkowitzRS，et al.Update on the diagnosis and management of gestational trophoblastic disease［J］.International Journal of Gynecology and Obstetrics，2015，131: S123-S126.
［6］Oslerud B, Bjorklid. The tissue factor pathway in disseminated intra-vascular coagulation ［J］. Seminars in Thrombosis&Hem ostasis, 2001, 27(6): 605-617.
［7］Erez O, Gotsch F, Mazaki-Tovi S, et al. Evidence of maternal platelet activation, excessive thrombin generation, and high amniotic fluid tissue factor immunoreactivity and functional activity in patients with fetal death ［J］. J Matern Fetal Neonatal Med, 2009, 22(8): 672-687.
［8］Hossain N，Paidas MJ.Disseminated intravascular coagulation ［J］.Semin Perinatol，2013,37:257-266.
［9］Wikkelsoe AJ, Afshari A, Stensballe JA, et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial ［J］. Trials, 2012, 13(1): 110.